XNAS
HTGC
Market cap4.59bUSD
Oct 08, Last price
16.55USD
1D
1.16%
1Q
3.37%
Jan 2017
200.25%
IPO
944.08%
Name
Hercules Capital Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hercules Capital, Inc. is a business development company. It focuses on venture lending capital-backed companies in the technology and life science industries. The company was founded in December 2003 and is headquartered in San Mater, CA.
Key people
Scott Bluestein
President, Chief Executive Officer, Director · since 2019
Seth H. Meyer
Chief Financial Officer · since 2019
Melanie Grace
Chief Compliance Officer, General Counsel, Secretary · since 2015
Manuel A. Henriquez
Director · since 2019
Robert P. Badavas
Independent Chairman of the Board · since 2019
Independent Director · since 2014
Carol L. Foster
Independent Director · since 2019
Joseph F. Hoffman
Independent Director · since 2015
Brad Koenig
Independent Director · since 2017
Independent Director · since 2017
Doreen Woo Ho
Independent Director · since 2016
Legal address
C/O UNITED AGENT GROUP INC.
2405 YORK ROAD
SUITE 201-C
LUTHERVILLE-TIMONIUM, MD 21093
US
2405 YORK ROAD
SUITE 201-C
LUTHERVILLE-TIMONIUM, MD 21093
US
Headquarters
SUITE 820
7 ST. PAUL STREET
BALTIMORE, MD 21202
US
7 ST. PAUL STREET
BALTIMORE, MD 21202
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||